Interatrial shunt therapy in advanced heart failure: Outcomes from the open ‐label cohort of the RELIEVE‐HF trial

ConclusionInteratrial shunting with the Ventura device was safe and resulted in favourable clinical effects in patients with HF, regardless of LVEF. Improvements of left and right ventricular structure and function were consistent with reverse myocardial remodelling. These results would support the potential of this shunt device as a treatment for HF.

Source: European Journal of Heart Failure - April 2, 2024 Category: Cardiology Authors: Josep Rod és‐Cabau, JoAnn Lindenfeld, William T. Abraham, Michael R. Zile, Saibal Kar, Antoni Bayés‐Genís, Neal Eigler, Richard Holcomb, Julio Núñez, Elizabeth Lee, Michal Laufer Perl, Gil Moravsky, Michael Pfeiffer, John Boehmer, J Tags: Research Article Source Type: research